Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Betazole is a synthetic small molecule and a pyrazole analogue of histamine that acts as a selective agonist at the histamine H2 receptor. Its primary clinical use is as a diagnostic agent to stimulate gastric acid secretion for the assessment of gastric secretory function. Betazole is used in tests to diagnose conditions such as Zollinger-Ellison syndrome (characterized by excessive gastric acid production) and gastritis. It offers an advantage over direct histamine stimulation due to its specificity for the H2 receptor, resulting in fewer side effects and eliminating the need for antihistaminic premedication. Betazole increases gastric acid secretion by binding to and activating the H2 receptor on parietal cells in the stomach[1][3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on betazole.